Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever

New England Journal of Medicine

Volumn 355, Issue 2, 2006, Pages 148-155

  Hasin, Tal ^a,d   Davidovitch, Nadav ^a   Cohen, Regev ^a   Dagan, Tsachi ^a   Romem, Ayal ^a   Orr, Nadav ^a   Klement, Eyal ^a   Lubezky, Nir ^a   Kayouf, Raid ^a   Sela, Tamar ^a   Keller, Nathan ^b   Derazne, Estela ^a   Halperin, Tamar ^a   Yavzori, Miri ^a   Grotto, Itamar ^a   Cohen, Dani ^c  

^a MEDICAL CORPS   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Tel Aviv University ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEXXON; DOXYCYCLINE; PLACEBO;

ARTICLE; BLOOD SMEAR; BORRELIA BURGDORFERI; BORRELIA INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; GENE; GENETIC ANALYSIS; GLPQ GENE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TICK BORNE DISEASE;

EID: 33745900780     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa053884     Document Type: Article

References (25)

1. Dennis DT, Campbell GL. Relapsing fever. In: Fauci AS, Braunwald E, Isselbacher KJ, et al., eds. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill, 1998:1038-42.
2. Burgdorfer W, Varma MG. Trans-stadial and transovarial development of disease agents in arthropods. Annu Rev Entomol 1967;12:347-76.
3. Egoz N, Lerman Y, Koufman Z. The epidemiology of relapsing fever in the Israel Defense Forces, 1966-76. Harefuah 1978;95:367-70. (In Hebrew.)
4. Lerman Y, Koufman Z, Egoz N. The clinical picture of relapsing fever in the Israel Defense Forces, 1966-76. Harefuah 1978;95:365-7. (In Hebrew.)
5. Johnson WD, Golightly LM. Borrelia species (relapsing fever). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:2502-4.
6. Barbour AG. Relapsing fever and other borrelia infections. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens & practice. Philadelphia: Churchill Livingstone, 1999:535-46.
7. Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 1998;26:151-64.
8. Megiddo D. A case survey of acute relapsing fever in Israel. Harefuah 1984;107:142-5. (In Hebrew)
9. Dworkin MS, Anderson DE Jr, Schwan TG, et al. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis 1998;26:122-31.
10. Rosa PA, Schwan TG. A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction. J Infect Dis 1989;160:1018-29.
11. van Dam AP, van Gool T, Wetsteyn JC, Dankert J. Tick-borne relapsing fever imported from West Africa: diagnosis by quantitative buffy coat analysis and in vitro culture of Borrelia crocidurae. J Clin Microbiol 1999;37:2027-30.
12. Baradaran-Dilmaghani R, Stanek G. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics. Infection 1996;24:60-3.
13. Warrell DA, Perine PL, Krause DW, Bing DH, MacDougal SJ. Pathophysiology and immunology of the Jarisch-Herxheimer-like reaction in louse-borne relapsing fever: comparison of tetracycline and slow-release penicillin. J Infect Dis 1983;147:898-909.
14. Teklu B, Habte-Michael A, Warrell DA, White NJ, Wright DJ. Meptazinol diminishes the Jarisch-Herxheimer reaction of relapsing fever. Lancet 1983;1:835-9.
15. Negussie Y, Remick DG, DeForge LE, Kunkel SL, Eynon A, Griffin GE. Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever. J Exp Med 1992;175:1207-12.
16. Korenberg EI, Vorobyeva NN, Moskvitina HG, Gorban' LYa. Prevention of borreliosis in persons bitten by infected ticks. Infection 1996;24:187-9.
17. Nadelman RB, Nowakowski J, Fish D, et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001;345:79-84.
18. Galun E, Ben Chetrit E. Possible prevention of tick-borne relapsing fever in patients infected with Borrelia recurrentis. J Infect Dis 1984;150:617.
19. Raz R, Sharir R, Bennett M. Prevention of Borrelia recurrentis infection with tetracycline. Isr J Med Sci 1987;23:221.
20. Wilske B, Schriefer ME. Borrelia. In: Murray PR, Barron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology. 8th ed. Washington, D.C.: ASM Press, 2003:941-3.
21. Gracia L, Robin Y, Shimizu RY, Paltridge GP. Algorithm for detection and identification of parasites. In: Murray PR, Barron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology. 8th ed. Washington, D.C.: ASM Press, 2003:1934-7.
22. Halperin T, Orr N, Cohen R, et al. Detection of relapsing fever in human blood samples from Israel using PCR targeting the glycerophosphodiester phosphodiesterase (GlpQ) gene. Acta Tropica 2006;98:189-95.
23. Porcella SF, Raffel SJ, Schrumpf ME, Schriefer ME, Dennis DT, Schwan TG. Serodiagnosis of louse-borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis. J Clin Microbiol 2000;38:3561-71.
24. de Clercq AG, Meheus AZ, de Pierpont E, Nyirashema C. Single-dose doxycycline treatment of tick-borne relapsing fever. East Afr Med J 1975;52:428-9.
25. Liles WC, Spach DH. Late relapse of tick-borne relapsing fever following treatment with doxycycline. West J Med 1993;158:200.